Market overview
The global ophthalmic gas delivery market is worth USD 74 mn in 2026 and is forecast to reach USD 117 mn by 2036, growing at a 4.8% CAGR. United States is the largest country market and SF6 is the largest by gas segment.
| Scope | Sterile expansile gases and delivery sets injected into the eye during retinal detachment and macular hole surgery, mainly SF6 and C3F8 with air-gas mixing kits. |
|---|---|
| Industry | Healthcare |
| Value 2025 | USD 70 mn |
| Value 2026 | USD 74 mn |
| Value 2036 | USD 117 mn |
| CAGR 2026-2036 | 4.8% |
| Volume 2026 | 364 thousand units |
| Volume 2036 | 526 thousand units |
| Average price 2026 | USD 202 per unit |
| Report price | Starts from USD 1,999 |
| Published | November 2026 |
Request a free sample of this report
Ophthalmic Gas Delivery market size and forecast, 2026-2036
Source: Compare Market Research analysis.
© 2026 Compare Market Research. All rights reserved.
| Year | Market value |
|---|---|
| 2026 | USD 74 mn |
| 2027 | USD 77 mn |
| 2028 | USD 81 mn |
| 2029 | USD 85 mn |
| 2030 | USD 89 mn |
| 2031 | USD 93 mn |
| 2032 | USD 97 mn |
| 2033 | USD 102 mn |
| 2034 | USD 107 mn |
| 2035 | USD 112 mn |
| 2036 | USD 117 mn |
Ophthalmic Gas Delivery market segmentation
By gas
Source: Compare Market Research analysis.
© 2026 Compare Market Research. All rights reserved.
| Segment | Share 2026 | Share 2036 | Value 2026 | CAGR 2026-36 |
|---|---|---|---|---|
| SF6 | 48.0% | 46.3% | USD 35 mn | 4.4% |
| C3F8 | 42.0% | 42.5% | USD 31 mn | 4.9% |
| Gas mixtures and air | 10.0% | 11.1% | USD 7.3 mn | 5.9% |
By end use
Source: Compare Market Research analysis.
© 2026 Compare Market Research. All rights reserved.
| Segment | Share 2026 | Share 2036 | Value 2026 | CAGR 2026-36 |
|---|---|---|---|---|
| Hospitals | 56.0% | 52.8% | USD 41 mn | 4.2% |
| Eye surgery centres | 30.0% | 32.6% | USD 22 mn | 5.7% |
| Specialty clinics | 14.0% | 14.5% | USD 10 mn | 5.2% |
By application
| Segment | Share 2026 | Share 2036 | Value 2026 | CAGR 2026-36 |
|---|---|---|---|---|
| Retinal detachment repair | 48.0% | 46.0% | USD 35 mn | 4.3% |
| Macular hole surgery | 26.0% | 26.0% | USD 19 mn | 4.8% |
| Pneumatic retinopexy | 14.0% | 15.0% | USD 10 mn | 5.5% |
| Other vitreoretinal surgery | 12.0% | 13.0% | USD 8.8 mn | 5.6% |
By delivery system
| Segment | Share 2026 | Share 2036 | Value 2026 | CAGR 2026-36 |
|---|---|---|---|---|
| Prefilled syringes and cartridges | 40.0% | 40.0% | USD 29 mn | 4.8% |
| Gas cylinders with regulators | 36.0% | 32.0% | USD 26 mn | 3.6% |
| Gas mixing and filling systems | 24.0% | 28.0% | USD 18 mn | 6.4% |
By purity grade
| Segment | Share 2026 | Share 2036 | Value 2026 | CAGR 2026-36 |
|---|---|---|---|---|
| Medical grade | 66.0% | 60.0% | USD 49 mn | 3.8% |
| High-purity surgical grade | 24.0% | 28.0% | USD 18 mn | 6.4% |
| Sterile prefilled grade | 10.0% | 12.0% | USD 7.3 mn | 6.7% |
Top 25 countries for ophthalmic gas delivery by revenue
Countries are ranked by revenue earned from sales in the country, not by where the product is made. The ten largest hold 85.0% of 2026 revenue and the 25 countries below together hold 96.1%.
Source: Compare Market Research analysis.
© 2026 Compare Market Research. All rights reserved.
| # | Country | Value 2026 | Share 2026 | Value 2036 | CAGR 2026-36 |
|---|---|---|---|---|---|
| 1 | United States | USD 21 mn | 28.0% | USD 31 mn | 4.3% |
| 2 | China | USD 10 mn | 14.0% | USD 20 mn | 6.8% |
| 3 | Japan | USD 7.3 mn | 10.0% | USD 11 mn | 3.8% |
| 4 | Germany | USD 5.9 mn | 8.0% | USD 8.6 mn | 3.8% |
| 5 | India | USD 4.4 mn | 6.0% | USD 8.9 mn | 7.3% |
| 6 | France | USD 3.7 mn | 5.0% | USD 5.3 mn | 3.7% |
| 7 | United Kingdom | USD 2.9 mn | 4.0% | USD 4.2 mn | 3.7% |
| 8 | Italy | USD 2.9 mn | 4.0% | USD 4.2 mn | 3.7% |
| 9 | South Korea | USD 2.2 mn | 3.0% | USD 3.6 mn | 5.1% |
| 10 | Brazil | USD 2.2 mn | 3.0% | USD 3.5 mn | 4.8% |
| 11 | Canada | USD 1.1 mn | 1.5% | USD 1.8 mn | 4.6% |
| 12 | Australia | USD 1.00 mn | 1.4% | USD 1.6 mn | 4.6% |
| 13 | Spain | USD 0.87 mn | 1.2% | USD 1.4 mn | 4.6% |
| 14 | Netherlands | USD 0.77 mn | 1.1% | USD 1.2 mn | 4.6% |
| 15 | Russia | USD 0.68 mn | 0.9% | USD 1.1 mn | 4.6% |
| 16 | Turkey | USD 0.60 mn | 0.8% | USD 0.94 mn | 4.7% |
| 17 | Mexico | USD 0.57 mn | 0.8% | USD 0.89 mn | 4.7% |
| 18 | Taiwan | USD 0.49 mn | 0.7% | USD 0.75 mn | 4.5% |
| 19 | Poland | USD 0.40 mn | 0.6% | USD 0.63 mn | 4.6% |
| 20 | Sweden | USD 0.36 mn | 0.5% | USD 0.56 mn | 4.6% |
| 21 | Switzerland | USD 0.34 mn | 0.5% | USD 0.53 mn | 4.6% |
| 22 | Belgium | USD 0.29 mn | 0.4% | USD 0.46 mn | 4.8% |
| 23 | Indonesia | USD 0.24 mn | 0.3% | USD 0.39 mn | 4.8% |
| 24 | Thailand | USD 0.21 mn | 0.3% | USD 0.34 mn | 4.8% |
| 25 | Saudi Arabia | USD 0.19 mn | 0.3% | USD 0.29 mn | 4.4% |
| Rest of world | USD 2.9 mn | 3.9% | USD 4.5 mn | 4.5% |
Source: Compare Market Research analysis.
© 2026 Compare Market Research. All rights reserved.
Competitive landscape
Group 1: Global leaders
- Alcon
- Bausch + Lomb
- Carl Zeiss Meditec
Group 2: Regional and specialist players
- DORC
- ALCHIMIA
- Fluoron
Group 3: Emerging and niche players
- Air Liquide
- Rumex International
Research methodology
Every figure on this page comes from the research framework that we apply to all of the markets we cover. The 2025 base for the ophthalmic gas delivery market is built from the volume sold and the price that buyers pay, and is cross-checked against the size of the wider industry the market belongs to. Where a market can be sized in more than one way, the routes are compared before a figure is set.
The forecast runs year by year from the 2025 base to 2036. Growth in each year reflects demand from the industries that buy the product, adoption of new technology, pricing, regulation and replacement cycles. Volume and price are modelled together, so revenue in each year equals volume multiplied by average price. The 2026 to 2036 compound annual growth rate of 4.8% is calculated from the resulting values.
The market is divided by gas, by end use, by application, by delivery system, by purity grade. The 25 largest countries are ranked by revenue earned from sales to buyers in each country, not by where the product is made. Segment values and country values add up to the market total in every year, and every report is checked for consistency before it is published.
Companies are placed in three groups: global leaders, regional and specialist players, and emerging and niche players. The groups describe how companies compete in the market. They are not a ranking and they are not market shares.
Our analysts also carry out primary research. Customized reports add interviews with key opinion leaders, such as senior executives, technical specialists and buyers, to test the assumptions behind the numbers for the question being asked.
Frequently asked questions
How big is the ophthalmic gas delivery market?
The global ophthalmic gas delivery market is estimated at USD 70 mn in 2025 and USD 74 mn in 2026.
How fast will the ophthalmic gas delivery market grow?
It is forecast to reach USD 117 mn by 2036, a compound annual growth rate of 4.8% from 2026, an increase of USD 44 mn.
Which country is the largest market for ophthalmic gas delivery?
United States is the largest market by revenue at USD 21 mn in 2026, 28.0% of the global total. The three largest countries together hold 52.0%.
Which country is growing fastest?
Among the ten largest markets, India is growing fastest at 7.3% a year from 2026 to 2036.
Which ophthalmic gas delivery segment is largest?
In the by gas split, SF6 is the largest segment with 48.0% of 2026 revenue.
Who are the leading ophthalmic gas delivery companies?
Global leaders include Alcon, Bausch + Lomb, Carl Zeiss Meditec.
Need the full report?
Request a sample to see the structure, tables and country detail.
Request a free sampleRelated markets in Healthcare
- Emergency Transfer Vacuum MattressUSD 74 mn · 5.0% CAGR
- Dual Lumen ECMO CatheterUSD 73 mn · 8.5% CAGR
- AI Osteoporosis Screening ToolsUSD 74 mn · 18.0% CAGR
- Touch Activated Phlebotomy DevicesUSD 72 mn · 18.0% CAGR
- Federated Learning HealthcareUSD 78 mn · 22.0% CAGR
- Vaccine CryoprotectantsUSD 81 mn · 8.0% CAGR
- AI Capsule Endoscopy Reading PlatformUSD 64 mn · 17.0% CAGR
- Respiration Monitor BeltUSD 63 mn · 5.2% CAGR
← Oncolytic Virus Cancer Therapy Ophthalmic Stereoscopic 3D Display →